{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:53Z","timestamp":1792802033127,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.beem.2023.101815","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:07:37Z","timestamp":1692706057000},"page":"101815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review"],"prefix":"10.1016","volume":"38","author":[{"given":"Petra","family":"Stute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus Josef","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Eicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pavicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Kolokythas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Theis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"von Gernler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Vollrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.beem.2023.101815_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2023.101815_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2022.04.008","article-title":"Menopause, wellbeing and health: a care pathway from the European Menopause and Andropause Society","volume":"163","author":"Lambrinoudaki","year":"2022","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2023.101815_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-022-02045-9","article-title":"Reducing systematic review burden using Deduklick: a novel, automated, reliable, and explainable deduplication algorithm to foster medical research","volume":"11","author":"Borissov","year":"2022","journal-title":"Syst Rev"},{"key":"10.1016\/j.beem.2023.101815_bib5","unstructured":"National Heart, L., and Blood Institute. Study Quality Assessment Tools. 2013 [cited 2023]."},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.","volume":"275","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/AOG.0000000000002645","article-title":"A 17\u03b2-estradiol-progesterone oral capsule for vasomotor symptoms in postmenopausal women: a randomized controlled trial","volume":"132","author":"Lobo","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/GME.0000000000001480","article-title":"Endometrial safety and bleeding profile of a 17\u03b2-estradiol\/progesterone oral softgel capsule (TX-001HR).","volume":"27","author":"Mirkin","year":"2020","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0378-5122(91)90093-6","article-title":"Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women","volume":"13","author":"Darj","year":"1991","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5122(86)90027-7","article-title":"Endometrial response in post-menopausal women during treatment with percutaneous 17 beta-oestradiol opposed by oral progesterone","volume":"8","author":"Holst","year":"1986","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5122(01)00260-2","article-title":"Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone","volume":"41","author":"Jondet","year":"2002","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00004347-200110000-00010","article-title":"Micronized progesterone regulation of the endometrial glandular cycling pool","volume":"20","author":"Moyer","year":"2001","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5122(01)00170-0","article-title":"Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause","volume":"40","author":"Pelissier","year":"2001","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.beem.2023.101815_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/09513590.2015.1019853","article-title":"Treatment of menopausal symptoms with three low-dose continuous sequential 17\u03b2-estradiol\/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology","volume":"31","author":"Cort\u00e9s-Bonilla","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.beem.2023.101815_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2021.09.002","article-title":"Use of oral estradiol plus vaginal progesterone in healthy postmenopausal women","volume":"154","author":"Sriprasert","year":"2021","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0015-0282(02)04542-9","article-title":"Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium","volume":"79","author":"Leonetti","year":"2003","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.beem.2023.101815_bib17","first-page":"36","article-title":"Transdermal progesterone cream as an alternative progestin in hormone therapy","volume":"11","author":"Leonetti","year":"2005","journal-title":"Alter Ther Health Med"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-5122(00)00176-6","article-title":"Endometrial safety of continuous combined hormone replacement therapy with 17beta-oestradiol (1 or 2 mg) and dydrogesterone","volume":"37","author":"Bergeron","year":"2001","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.maturitas.2005.05.015","article-title":"Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile","volume":"53","author":"Quereux","year":"2006","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1471-0528.1995.tb09102.x","article-title":"A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol","volume":"102","author":"Burch","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00042192-200310020-00010","article-title":"Comparison of the difference in histopathology and cell cycle kinetics among the postmenopausal endometrium treated with different progestins in sequential-combined hormone replacement therapy","volume":"10","author":"Chang","year":"2003","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/cmt.5.1.26.35","article-title":"Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5\u201320\u2009mg dydrogesterone","volume":"5","author":"Ferenczy","year":"2002","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib23","first-page":"10","article-title":"Conjugated estrogens combined with sequential dydrogesterone or medroxyprogesterone acetate in postmenopausal women: effects on lipoproteins, glucose tolerance, endometrial histology, and bleeding","volume":"4","author":"Gelfand","year":"1997","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-5122(97)00037-6","article-title":"Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users","volume":"27","author":"H\u00e4nggi","year":"1997","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-5122(91)90142-D","article-title":"A first study to compare two dosages of dydrogesterone in opposing the 50 mg oestradiol implant","volume":"14","author":"Rees","year":"1991","journal-title":"Maturitas"},{"issue":"12","key":"10.1016\/j.beem.2023.101815_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1471-0528.1990.tb02497.x","article-title":"Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone","volume":"97","author":"Siddle","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13697139909025573","article-title":"Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone","volume":"2","author":"van de Weijer","year":"1999","journal-title":"Climacteric"},{"issue":"13","key":"10.1016\/j.beem.2023.101815_bib28","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib29","first-page":"205","article-title":"Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin","volume":"33","author":"Bewtra","year":"1988","journal-title":"J Reprod Med"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0378-5122(01)00245-6","article-title":"Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study","volume":"40","author":"Bruhat","year":"2001","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib31","first-page":"523","article-title":"Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium","volume":"79","author":"Byrjalsen","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv350","article-title":"Continuous combined estrogen plus progestin and endometrial cancer: the Women's Health Initiative Randomized Trial","volume":"108","author":"Chlebowski","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/1362180043654647","article-title":"Long-term safety and tolerability of continuous-combined hormone therapy in postmenopausal women: results from a seven-year randomised comparison of low and standard doses","volume":"10","author":"Heikkinen","year":"2004","journal-title":"J Br Menopause Soc"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1258\/136218006778234093","article-title":"A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings","volume":"12","author":"Heikkinen","year":"2006","journal-title":"J Br Menopause Soc"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00042192-200201000-00004","article-title":"Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy","volume":"9","author":"Johnson","year":"2002","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0378-5122(94)90075-2","article-title":"Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use","volume":"19","author":"Marslew","year":"1994","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13697130310001651481","article-title":"A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen","volume":"7","author":"Mattsson","year":"2004","journal-title":"Climacteric"},{"issue":"1\u20132","key":"10.1016\/j.beem.2023.101815_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0301-2115(96)02493-1","article-title":"Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium","volume":"68","author":"Pansini","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib39","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0015-0282(03)01167-1","article-title":"Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results","volume":"80","author":"Pickar","year":"2003","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mob.2003.335","article-title":"Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study","volume":"189","author":"Pinto","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.beem.2023.101815_bib41","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0002-9378(87)80242-9","article-title":"Continuous estrogen\/progestin therapy in menopause","volume":"157","author":"Prough","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-0528.2002.01167.x","article-title":"Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response","volume":"109","author":"Raudaskoski","year":"2002","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13697130310001651445","article-title":"Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate\/medroxyprogesterone acetate therapy regimen","volume":"7","author":"Rees","year":"2004","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib44","first-page":"773","article-title":"Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology","volume":"82","author":"Ross","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.beem.2023.101815_bib46","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0002-9378(90)90917-V","article-title":"Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient","volume":"162","author":"Weinstein","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0002-9378(90)90402-S","article-title":"A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement","volume":"162","author":"Williams","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib48","first-page":"787","article-title":"Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement","volume":"84","author":"Williams","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/j.beem.2023.101815_bib49","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0002-9378(13)90437-3","article-title":"Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group","volume":"170","author":"Woodruff","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00404-005-0099-6","article-title":"Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding","volume":"273","author":"Yildirim","year":"2006","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.GME.0000117062.54779.BD","article-title":"Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women","volume":"11","author":"Utian","year":"2004","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-5122(93)90054-L","article-title":"Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate\/cyproterone acetate preparation","volume":"16","author":"Koninckx","year":"1993","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-5122(89)90117-5","article-title":"The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy","volume":"11","author":"Fraser","year":"1989","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09513590500168464","article-title":"Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol\/trimegestone versus 1 or 2 mg 17beta-estradiol\/norethisterone acetate in postmenopausal women","volume":"21","author":"Bouchard","year":"2005","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/09513590500168472","article-title":"A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women","volume":"21","author":"Koninckx","year":"2005","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/gye.15.5.349.358","article-title":"A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone","volume":"15","author":"Meuwissen","year":"2001","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(03)00163-4","article-title":"Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT","volume":"46","author":"Boon","year":"2003","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1471-0528.2000.tb13230.x","article-title":"Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium","volume":"107","author":"Byrjalsen","year":"2000","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib59","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0015-0282(16)53341-X","article-title":"The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study","volume":"53","author":"Fraser","year":"1990","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib60","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/13697137.2013.783797","article-title":"One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone\/0.5 mg 17\u03b2-estradiol in postmenopausal women","volume":"16","author":"Genazzani","year":"2013","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697130009167612","article-title":"Comparison of the efficacy and endometrial safety of two estradiol valerate\/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women","volume":"3","author":"Gr\u00e4ser","year":"2000","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib62","first-page":"393","article-title":"Is dosage of hormone replacement therapy related with endometrial polyp formation?","volume":"27","author":"Iatrakis","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib63","first-page":"373","article-title":"Norethindrone acetate and estradiol-induced endometrial hyperplasia","volume":"96","author":"Kurman","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib64","first-page":"407","article-title":"Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women","volume":"83","author":"Limpaphayom","year":"2000","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0378-5122(93)90129-6","article-title":"A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment","volume":"16","author":"Obel","year":"1993","journal-title":"Maturitas"},{"issue":"1 Pt 1","key":"10.1016\/j.beem.2023.101815_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0002-9378(95)90095-0","article-title":"Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses","volume":"172","author":"Raudaskoski","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.beem.2023.101815_bib67","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinthera.2006.06.013","article-title":"Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg\/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials","volume":"28","author":"Rowan","year":"2006","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0020-7292(00)00342-8","article-title":"Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms","volume":"72","author":"Rozenberg","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2007.01.001","article-title":"One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women","volume":"57","author":"Samsioe","year":"2007","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/13697130600953661","article-title":"Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study","volume":"9","author":"Samsioe","year":"2006","journal-title":"Climacteric"},{"issue":"10","key":"10.1016\/j.beem.2023.101815_bib71","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-0528.1988.tb06511.x","article-title":"Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints","volume":"95","author":"Sporrong","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5122(95)00949-3","article-title":"17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy","volume":"23","author":"Stadberg","year":"1996","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13697130701852390","article-title":"Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women","volume":"11","author":"Sturdee","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.beem.2023.101815_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-94-011-5560-1_36","article-title":"Effects of quarterly hormone replacement therapy on climacteric symptoms, endometrial safety, and lipoproteins","author":"van der Mooren","year":"1997","journal-title":"Women'S Heal Menopause"},{"issue":"1","key":"10.1016\/j.beem.2023.101815_bib75","first-page":"61","article-title":"Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations","volume":"94","author":"Mattsson","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.beem.2023.101815_bib76","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/humrep\/dep067","volume":"24","author":"Rozenberg","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.beem.2023.101815_bib77","first-page":"17","article-title":"Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized post-menopausal endometrium","volume":"106","author":"Siddle","year":"1981","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib78","first-page":"498","article-title":"A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group","volume":"94","author":"Archer","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042192-200203000-00009","article-title":"Low dose transdermal estradiol\/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women","volume":"9","author":"Brynhildsen","year":"2002","journal-title":"Menopause"},{"issue":"Suppl 2","key":"10.1016\/j.beem.2023.101815_bib80","first-page":"388","article-title":"Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium","volume":"42","author":"Johannisson","year":"1997","journal-title":"Int J Fertil Women\u2019s Med"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5122(00)00155-9","article-title":"Efficacy and tolerability of fully transdermal hormone replacement in sequential or continuous therapy at two doses of progestogen in postmenopausal women","volume":"37","author":"Ylikorkala","year":"2000","journal-title":"Maturitas"},{"issue":"8","key":"10.1016\/j.beem.2023.101815_bib82","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/oxfordjournals.humrep.a137791","article-title":"Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy","volume":"7","author":"Byrjalsen","year":"1992","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1590\/S1519-38292013000300007","article-title":"Effects of hormone therapy on the endometrium in postmenopausal women: a one year randomized trial of low dose oral estradiol in association with a levonorgestrel-releasing intrauterine system or drospirenone","volume":"13","author":"Schvartzman","year":"2013","journal-title":"Rev Bras Saude Matern Infant"},{"issue":"5","key":"10.1016\/j.beem.2023.101815_bib84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/00016349709047827","article-title":"Intrauterine administration of levonorgestrel 5 and 10 microg\/24\u2009h in perimenopausal hormone replacement therapy. A randomized clinical study during one year","volume":"76","author":"Wollter-Svensson","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib85","first-page":"170","article-title":"Endometrial safety of a transdermal sequential estradiol-levonorgestrel combination","volume":"5","author":"Sturdee","year":"2002","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00042192-200205000-00008","volume":"9","author":"Shulman","year":"2002","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.beem.2023.101815_bib87","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/humrep\/16.6.1244","article-title":"A prospective randomized controlled study comparing two doses of gestodene in cyclic combined HRT preparations on endometrial physiology","volume":"16","author":"Okon","year":"2001","journal-title":"Hum Reprod"},{"issue":"1\u20132","key":"10.1016\/j.beem.2023.101815_bib88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0378-5122(95)01020-3","article-title":"Endometrial response in estrogen replacement therapy quarterly combined with a progestogen","volume":"24","author":"Boerrigter","year":"1996","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.beem.2023.101815_bib89","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.beem.2023.101815_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/GME.0b013e31829c1431","article-title":"A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17\u03b2-estradiol for moderate to severe vasomotor symptoms in postmenopausal women","volume":"21","author":"Archer","year":"2014","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.beem.2023.101815_bib91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/13697130801983921","article-title":"Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause","volume":"11","author":"Birkhauser","year":"2008","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.beem.2023.101815_bib92","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513590009167694","article-title":"Low incidence of endometrial hyperplasia with acceptable bleeding patterns in women taking sequential hormone replacement therapy with dydrogesterone","volume":"14","author":"Bergeron","year":"2000","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2023.101815_bib93","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/gme.0b013e31821606c5","article-title":"Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis","volume":"18","author":"Somboonporn","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.beem.2023.101815_bib94","unstructured":"U.S. Department of Health and Human Services, Fa.D.A., Center for Drug Evaluation und Research (CDER), Guidance for Industry. Estrogen and estrogen\/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms-recommendations for clinical evaluation. January 2003."},{"issue":"41","key":"10.1016\/j.beem.2023.101815_bib95","first-page":"1","article-title":"Combined hormonal replacement therapy and the risk of endometrial cancer in postmenopausal women: a meta-analysis","volume":"20","author":"Sayedali","year":"2022","journal-title":"Indian J Gynecol Oncol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:00:46Z","timestamp":1761498046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1521690X23000891"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101815","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101815"}}